Research lines of Ischaemic Heart Disease

Research into Ischaemic heart disease seeks to prevent the disease’s progression, and improve treatment and patient prognosis. 

• Under study are different combinations of anti-platelet drugs to reduce the risk of both bleeding and thrombus production.
• To slow the progression of the disease, studies have been designed with medications that can modify LDL cholesterol (“bad” cholesterol) and Lipoprotein(a) levels, or improve the management and control of diabetes and high blood pressure.
• To prevent the recurrence of angina or heart attacks, adherence to medication and lifestyle changes is essential. For this purpose, new molecules have been developed that combine multiple active ingredients into a single pill, along with long-acting drugs that can be administered once a week, once a month, or once every six months.
• Work is continually being done on developing novel stent models with a lower thrombosis rate that do not interfere with any future bypass surgery performed. Similarly, the best surgical techniques to improve the durability of the bypass are also being studied.